How to talk to your doctor about psilocybin — what works, what doesn't
58 replies · Therapy & Healing
I recently had a conversation with my psychiatrist about psilocybin. It went better than I expected once I figured out the right framing. I want to share what I learned, and hear from others who've had similar conversations. The short version: lead with the research, not with personal interest. My psychiatrist didn't know the COMPASS trial data. Once I showed him peer-reviewed publications, the conversation completely changed.
The framing that works: 'I've been reading about the clinical research on psilocybin-assisted therapy — there are Phase 2b and Phase 3 trials showing effect sizes of 2+ for treatment-resistant depression. I wanted to get your perspective on whether this might be relevant to my situation.' Do NOT start with 'I want to try mushrooms.' That framing closes the conversation before it starts.
Useful resources to bring to the appointment: 1. The NEJM paper on psilocybin vs. escitalopram (2021, Carhart-Harris et al.) 2. The COMPASS Phase 2b paper 3. The NYU smoking cessation data (80% abstinence at 6 months) Print them out or share links. Doctors respond to peer-reviewed data in recognized journals.
What if the doctor is dismissive? Some will be. Two options: 1. Find a physician who has done training in psychedelic medicine (MAPS, CIIS certificate programs) — they're increasingly common and will have actual informed opinions. 2. Use MAPS Provider Network or the Psychedelic Medicine Association to find informed practitioners. Don't waste energy trying to educate a doctor who's already closed the conversation.
One thing that changed my doctor's response: mentioning that the 2026 VA directive mandates access to psilocybin research for veterans, and that Australia has already approved psilocybin therapy nationally. Showing that this is moving into mainstream medicine — not just fringe — shifted the tone.
54 more replies — forum posting coming soon.